Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dihydroquinidine
2. Dihydroquinine
3. Hydroquinidine
4. Hydroquinidine Dihydrochloride, (1beta,4beta,3s)-(+-)-isomer
5. Hydroquinidine Dihydrochloride, (3alpha,9s)-(+-)-isomer
6. Hydroquinidine Hydrochloride
7. Hydroquinidine Monosulfate
8. Hydroquinidine Monosulfate, (1beta,3alpha,4beta,8alpha,9r)-isomer
9. Hydroquinidine Monosulfate, (1beta,3alpha,4beta,9s)-isomer
10. Hydroquinidine Sulfate
11. Hydroquinidine Sulfate, (9s)-isomer
12. Hydroquinidine, (+-)-isomer
13. Hydroquinidine, (1beta, 3alpha,4beta,8alpha,9r)-isomer
14. Hydroquinidine, (1beta,3alpha,4beta,9s)-isomer
15. Hydroquinidine, (1beta,4beta,9s)-(+-)-isomer
16. Hydroquinidine, (3alpha,9s)-(+-)-isomer
17. Hydroquinidine, (8alpha,9r)-isomer
18. Hydroquinidine, (8alpha,9s)-isomer
19. Hydroquinidine, (9r)-isomer
20. Hydroquinidine, (9s)-(+-)-isomer
21. Lcn 834
22. Lcn-834
23. Lentoquine
24. Srcor
1. Dihydroquinine
2. Chembl2079611
3. (-)-hydroquinine
4. 10,11-dihydroquinine
5. (-)-10,11-dihydroquinine
6. Nsc-41799
7. 522-66-7
8. Schembl109602
9. Bdbm50407154
10. Cs-w019883
11. Hy-42034
12. J3.558.731d
13. (r)-(5-ethyl-1-azabicyclo[2.2.2]octane-2-yl)(6-methoxy-4-quinolinyl)methanol
| Molecular Weight | 326.4 g/mol |
|---|---|
| Molecular Formula | C20H26N2O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 326.199428076 g/mol |
| Monoisotopic Mass | 326.199428076 g/mol |
| Topological Polar Surface Area | 45.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 432 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
M - Musculo-skeletal system
M09 - Other drugs for disorders of the musculo-skeletal system
M09A - Other drugs for disorders of the musculo-skeletal system
M09AA - Quinine and derivatives
M09AA01 - Hydroquinine
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Dihydroquinine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroquinine, including repackagers and relabelers. The FDA regulates Dihydroquinine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroquinine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihydroquinine supplier is an individual or a company that provides Dihydroquinine active pharmaceutical ingredient (API) or Dihydroquinine finished formulations upon request. The Dihydroquinine suppliers may include Dihydroquinine API manufacturers, exporters, distributors and traders.
Dihydroquinine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydroquinine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroquinine GMP manufacturer or Dihydroquinine GMP API supplier for your needs.
A Dihydroquinine CoA (Certificate of Analysis) is a formal document that attests to Dihydroquinine's compliance with Dihydroquinine specifications and serves as a tool for batch-level quality control.
Dihydroquinine CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroquinine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydroquinine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroquinine EP), Dihydroquinine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroquinine USP).
LOOKING FOR A SUPPLIER?
